Mortality in adult congenital heart disease. Eur Heart J. 2010;31:1220 9. S2.2-6. Khairy P, Aboulhosn J, Gurvitz MZ, et al. Arrhythmia burden in adults with surgically repaired tetralogy of Fallot: a multi-institutional study. Circulation. 2010;122:868 75. S2.2-7. Khairy P, Fernandes SM, Mayer JE Jr, et al. Long-term survival, modes of death, and predictors of mortality in patients with Fontan surgery. Circulation. 2008;117:85 92. S2.2-8. Khairy P, Harris L, Landzberg MJ, et al. Implantable cardioverter-defi- brillators in tetralogy of Fallot. Circulation. 2008;117:363 70. S2.2-9. Dimopoulos K, Diller G-P, Koltsida E, et al. Prevalence, predictors, and prognostic value of renal dysfunction in adults with congenital heart disease. Circulation. 2008;117:2320 8. S2.2-10. Dimopoulos K, Diller G-P, Giannakoulas G, et al. Anemia in adults with congenital heart disease relates to adverse outcome. J Am Coll Cardiol. 2009;54:2093 100. S2.2-11. Dimopoulos K, Diller G-P, Petraco R, et al. Hyponatraemia: a strong predictor of mortality in adults with congenital heart disease. Eur Heart J. 2010;31:595 601. S2.2-12. Diller G-P, Dimopoulos K, Okonko D, et al. Exercise intolerance in adult congenital heart disease: comparative severity, correlates, and prognostic implication. Circulation. 2005;112:828 35. S2.2-13. Buys R, Cornelissen V, Van De Bruaene A, et al. Measures of exer- cise capacity in adults with congenital heart disease. Int J Cardiol. 2011;153:26 30. S2.2-14. Gratz A, Hess J, Hager A. Self-estimated physical functioning poorly predicts actual exercise capacity in adolescents and adults with con- genital heart disease. Eur Heart J. 2009;30:497 504. S2.2-15. Dimopoulos K, Okonko DO, Diller G-P, et al. Abnormal ventilatory response to exercise in adults with congenital heart disease relates to cyanosis and predicts survival. Circulation. 2006;113:2796 802. S2.2-16. Inuzuka R, Diller G-P, Borgia F, et al. Comprehensive use of cardi- opulmonary exercise testing identifies adults with congenital heart disease at increased mortality risk in the medium term. 